academic article

• Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia..  Blood.  129:177-187. 2017
• Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia..  Cancer cell.  22:153-166. 2012
• Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia..  Blood.  120:3510-3518. 2012